| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,885 | 942 | 943 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| HEALTHSOUTH | 179,850 | 153,480 |
| CALADRIUS BIOSCIENCES - FKA NEOSTEM | 100,191 | 4,294 |
| PHARMATHENE, INC | 291,343 | 246,050 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| MISC EXPENSE | 195 | 98 | 97 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| FEDERAL REFUND | 954 |
| Borrower's Name | Relationship to Insider | Original Amount of Loan | Balance Due | Date of Note | Maturity Date | Repayment Terms | Interest Rate | Security Provided by Borrower | Purpose of Loan | Description of Lender Consideration | Consideration FMV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHN PAPPAJOHN | SUBSTANTIAL CONTRIBUTOR | 652 | 652 | 2015-09 | AS SOON AS POSSIBLE | 0 % | NONE | CHARITABLE AND EDUCATIONAL PURPOSE | NONE |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX APPLIED | 954 |